Overdose deaths are increasing, despite efforts by governments to address illicit drug use and implement public health approaches. A significant reason is the increasing prevalence of xylazine (tranq), an alpha-2 adrenergic agonist and central nervous system depressant present in the fentanyl drug supply.

Post traumatic stress disorder (PTSD) is among the most common conditions facing U.S. Veterans, with no effective cure. Additionally, many Veterans use alcohol to alleviate their trauma, making medical treatment even more complex. For these high risk patients, Professors Christy Capone and Carolina Haass-Koffler are thinking outside the box: Could a treatment involving psychedelic drugs potentially save Veteran lives?

It’s imperative that we further our knowledge and understanding on smoking as a harm reduction strategy, and begin to identify and promote safer, evidence-based methods people can utilize while smoking to reduce health risks.